Showing 3651-3660 of 5693 results for "".
- Harrow Partners with Cencora to Launch “Harrow Cares” Programhttps://modernod.com/news/harrow-partners-with-cencora-to-launch-harrow-cares-program/2482637/Harrow announced the launch of its “Harrow Cares” program through a strategic partnership with Cencora. Harrow Cares is designed to deliver a suite of access and affordability services, enhancing support for retina specialists, their staff, and patients.
- SeaBeLife Reports Promising In Vivo Results for Ophthalmic Gel Candidate for GAhttps://modernod.com/news/seabelife-reports-promising-in-vivo-results-for-it-ophthalmic-gel-candidate-for-ga/2482635/SeaBeLife announced in vivo results for its SBL03 drug candidate, an ophthalmic gel designed to combat necrotic retinal cell death in geographic atrophy (GA). The primary objective of the preclinical study was to assess
- CooperVision Names Steven Robins as President, Americashttps://modernod.com/news/coopervision-names-steven-robins-as-president-americas/2482633/CooperVision has appointed Steven Robins as President, Americas, effective immediately. He has served for 3 decades in health care, with several high-profile corporate leadership and consulting roles in the vision care industry. Mr. Robins wa
- EMA Endorses Macustar's Work on Early AMD Clinical Trialshttps://modernod.com/news/ema-endorses-macustars-work-on-early-amd-clinical-trials/2482631/The European Medicines Agency (EMA) has issued its third 'Letter of Support' to the Macustar consortium, a European public-private partnership focused on advancing clinical trial methodologies for early-stage age-related macular degeneration (AMD). This endorsement follows the consortium&
- Hoya Vision Care Expands MiYOSMART Power Range for High Myopia Treatment in Childrenhttps://modernod.com/news/hoya-vision-care-expands-miyosmart-power-range-for-high-myopia-treatment-in-children/2482630/Hoya Vision Care announced the launch of an extended power range for its MiYOSMART spectacle lenses, offering a new solution for children suffering from high myopia. Designed specifically to address the needs of high myopic patients, the new lenses feature a broader range of prescriptions, slimme
- RayOne EMV Toric IOL Approved by Health Canadahttps://modernod.com/news/rayone-emv-toric-iol-approved-by-health-canada/2482626/Rayner announced the approval of RayOne EMV Toric IOL by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled positive spherical aberration to extend depth of focus, according
- Inflammasome Therapeutics Announces Positive Topline Data from K8 Implant Trial for GAhttps://modernod.com/news/inflammasome-therapeutics-announces-positive-topline-data-from-k8-implant-trial-for-geographic-atrophy/2482621/Inflammasome Therapeutics reported 3-month results from a clinical trial of its K8 implant in patients with geographic atrophy (GA). The study, conducted at the University of Kentucky (NCT06164587), demonstrated significant efficacy and safety following a single inject
- Visible Genomics Wins 2025 AMD Genetic Testing Company of the Year Awardhttps://modernod.com/news/visible-genomics-wins-2025-amd-genetic-testing-company-of-the-year-award/2482619/Visible Genomics, a provider of genetic testing solutions for severe ocular diseases, was named 'Life Sciences Review AMD Genetic Testing Company of the Year 2025.' This award recognizes the company’s innovative contributions to proactive care for advanced age-related macular degene
- AbbVie and Regenxbio Announce Updates on the ABBV-RGX-314 Clinical Program in DR and Wet AMDhttps://modernod.com/news/abbvie-and-regenxbio-announce-updates-on-the-abbv-rgx-314-clinical-program-in-dr-and-wet-amd/2482618/AbbVie and Regenxbio announced updates to the ABBV-RGX-314 gene therapy clinical program. Data from the ATMOSPHERE and ASCENT pivotal trials evaluating the safety and efficacy of the subretinal delivery of ABBV-RGX-314 in patients with wet AMD are expected in 2026. The co
- Specialty Contact Lens Division WAVE Eye Care Formedhttps://modernod.com/news/specialty-contact-lens-division-wave-eye-care-formed/2482616/EyePrint Prosthetics, Advanced Vision Technologies (AVT), and WAVE Contact Lens System—three providers of specialty contact lens fitting—have united to form WAVE Eye Care, a division dedicated to providing fully customized specialty contact lenses. According to a j